Medios AG | WebDisclosure

PRESS RELEASE

published on 05/12/2025 at 18:58, 1 year 4 months ago

Medios repositions itself for the next phase of its corporate development
Medios AG announces changes in Executive Board as part of corporate development transition. Founder and CEO to step down, COO to leave company. Focus on profitability and value creation. Professional search for CEO successor initiated

Profitability Executive Board Medios AG Corporate Development CEO Successor
PRESS RELEASE

published on 05/12/2025 at 18:56, 1 year 4 months ago

EQS-Adhoc: Changes to the Medios AG Executive Board; Matthias Gärtner will leave the company
Medios AG announces changes to its Executive Board with Matthias Gärtner, CEO, and Mi-Young Miehler, COO, leaving the company under mutual agreement for an organized transition

Executive Board Supervisory Board Medios AG Matthias Gärtner Mi-Young Miehler
BRIEF

published on 03/25/2025 at 07:55, 1 year 5 months ago

Medios AG Projects Continued Growth in 2025

Revenue Forecast Medios AG EBITDA Increase Specialty Pharma 2025 Growth
BRIEF

published on 03/25/2025 at 07:55, 1 year 5 months ago

Medios AG prévoit une croissance continue en 2025

Medios AG Prévisions De Revenus Augmentation De L'EBITDA Croissance 2025 Pharmaceutique Spécialisée
PRESS RELEASE

published on 03/25/2025 at 07:50, 1 year 5 months ago

Medios expects further growth in revenue and earnings after record year 2024
Medios expects further growth in revenue and earnings after a record year in 2024. Consolidated revenue up 5.5% to €1.9 billion. EBITDA pre1 margin reaches 4.2%. Positive outlook for 2025 with revenue expected to reach €2.0 billion

Revenue Growth Earnings Forecast Record Year Medios 2025 Outlook
BRIEF

published on 03/04/2025 at 08:55, 1 year 6 months ago

Medios AG Reports Strong Earnings Growth in 2024, Eyes Further Gains in 2025

Pharmaceutical Industry Medios AG Financial Growth 2024 Results 2025 Outlook
BRIEF

published on 03/04/2025 at 08:55, 1 year 6 months ago

Medios AG annonce une forte croissance de ses bénéfices en 2024 et prévoit de nouveaux gains en 2025

Croissance Financière Medios AG Résultats 2024 Industrie Pharmaceutique Perspectives 2025
PRESS RELEASE

published on 03/04/2025 at 08:50, 1 year 6 months ago

Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025
Medios AG reports significant increase in earnings and margins for 2024, positive outlook for 2025. Preliminary figures show revenue reaching €1.9 billion and EBITDA pre1 around €79 million

Revenue Outlook Earnings Medios AG Margins
BRIEF

published on 12/12/2024 at 13:32, 1 year 9 months ago

Medios AG Adjusts Full-Year Financial Forecast

Revenue Increase EBITDA Margin Financial Forecast Medios AG Specialty Pharma
BRIEF

published on 12/12/2024 at 13:32, 1 year 9 months ago

Medios AG ajuste ses prévisions financières pour l'ensemble de l'année

Medios AG Prévisions Financières Marge D'EBITDA Augmentation Des Revenus Spécialité Pharmaceutique

Published on 09/23/2026 at 22:00, 5 hours 49 minutes ago

Petrolympic Adopts Semi-Annual Financial Reporting
Published on 09/23/2026 at 18:25, 9 hours 24 minutes ago

Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 12 hours 7 minutes ago

Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 13 hours 18 minutes ago

First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 13 hours 19 minutes ago

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides

View all ACCESSWIRE

Published on 09/24/2026 at 03:24, 24 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: 2026 Notice of Annual General Meeting
Published on 09/23/2026 at 23:00, 4 hours 48 minutes ago

Correction d’un communiqué du 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNONCE LE SUCCÈS DE SON AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION AINSI QU’UN REMBOURSEMENT PARTIEL D’OBLIGATIONS REMBOURSABLES EN ACTIONS
Published on 09/23/2026 at 23:00, 4 hours 48 minutes ago

Correction of a release from 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNOUNCES THE SUCCESS OF ITS CAPITAL INCREASE WITH PREFERENTIAL SUBSCRIPTION RIGHTS AND THE PARTIAL EARLY REDEMPTION OF BONDS REDEEMABLE IN SHARES
Published on 09/23/2026 at 19:51, 7 hours 57 minutes ago

LIGHTON: LightOn renouvelle son financement obligataire auprès des mêmes partenaires financiers pour un montant nominal maximum de 4 millions d’euros, et étend ainsi son horizon de trésorerie
Published on 09/23/2026 at 19:51, 7 hours 57 minutes ago

LIGHTON: LightOn renews its bond financing with the same financial partners for a maximum nominal amount of €4 million, and thus extends its cash flow horizon

View all EQS

Published on 09/23/2026 at 19:46, 8 hours 2 minutes ago

SFPI GROUP: half year 2026 results
Published on 09/23/2026 at 19:46, 8 hours 2 minutes ago

SFPI GROUP: publication des résultats semestriels 2026
Published on 09/23/2026 at 19:14, 8 hours 34 minutes ago

Robust performance from Investments and continued execution of the strategy
Published on 09/23/2026 at 19:14, 8 hours 34 minutes ago

Performance robuste des Investissements, poursuite du déploiement de la stratégie
Published on 09/23/2026 at 18:00, 9 hours 49 minutes ago

CIS : H1 2026 results.

View all LES ECHOS COMFI WIRE

News